Impact of ICU Hospitalization on Kidney Graft Function
Factors for Impairment of Renal Graft Function in Intensive Care
This study looks at how being in the ICU affects kidney transplants over two years to help doctors take better care of patients' kidney function after critical illness.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Central Hospital, Nancy, France Academic / other |
| Locations | 1 site (Nancy) |
| Trial ID | NCT06191146 on ClinicalTrials.gov |
What this trial studies
This observational study aims to investigate how hospitalization in the intensive care unit (ICU) affects the function of kidney grafts over a period of up to two years. It focuses on identifying risk factors that contribute to renal graft degradation during and after ICU treatment. The study seeks to optimize the management of renal grafts in the ICU and improve follow-up care by nephrologists post-ICU. By analyzing patient outcomes, the research hopes to enhance strategies for preserving kidney function in critically ill patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have received a kidney graft and are hospitalized in the ICU for the first time.
Not a fit: Patients who were on chronic hemodialysis before ICU admission or those transferred to the ICU immediately after transplant may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for kidney grafts in ICU patients, potentially reducing the risk of graft failure.
How similar studies have performed: While this study explores a specific aspect of renal graft management in the ICU, similar studies have shown that understanding risk factors can lead to improved outcomes, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * kidney graft * \> 18 years * first hospitalization in ICU Exclusion Criteria: * chronic hemodialysis before ICU * transfer to intensive care immediately after transplant within 24 hours
Where this trial is running
Nancy
- CHRU Nancy — Nancy, France (Recruiting)
Study contacts
- Principal investigator: Sébastien GIBOT — CHU NANCY Central
- Study coordinator: charles ZAGOZDA
- Email: charles-zagozda@hotmail.fr
- Phone: 0684130446
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.